血细胞淋巴细胞瘤:当前的治疗进展,新兴的向疗法和潜在机制
Yijun Wu1,2,3,4, Xu Sun1,3,4, Kai Kang2,3,4
1Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Journal of hematology & oncology
|November 8, 2024
概括
血细胞淋巴细胞细胞瘤 (HLH) 是一种致命的疾病,由免疫过度激活驱动. 了解细胞因子风暴机制是开发超出单一批准治疗范围的HLH新向治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 临界护理医学 临界护理医学
背景情况:
- 血细胞淋巴细胞细胞瘤 (HLH) 是过度免疫激活的危及生命的综合征.
- 这种情况的特点是严重的细胞因子风暴,导致多器官衰竭和低生存率.
- 尽管增加了研究,但HLH的治疗选择仍然有限,仅有一种针对性治疗被批准用于原发性HLH.
研究的目的:
- 审查目前对HLH的治疗进展.
- 探索新兴的向疗法及其潜在机制.
- 为未来的治疗开发突出涉及HLH细胞因子风暴的新目标.
主要方法:
- 对当前和新兴HLH治疗方法的文献综述.
- 在HLH中驱动细胞因子风暴的机制分析.
- 确定潜在的新治疗点.
主要成果:
- 目前HLH治疗环境有限,epapalumab是初级HLH的唯一向治疗方法.
- 细胞因子风暴机制对于理解HLH病原和治疗至关重要.
- 已经确定了几种可能参与细胞因子风暴的新型目标.
结论:
- 对细胞因子风暴机制的进一步研究对于开发新型HLH疗法至关重要.
- 向治疗和多向组合策略显示出改善HLH疾病控制的前景.
- 需要进行额外的临床试验,以建立HLH的最佳治疗方案.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.1K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
